Vilya

A drug discovery company designing macrocyclic peptide therapeutics with AI, extending structure prediction and design beyond canonical chemistry.

Location: Seattle, WA, USA

1 model(1 Protein, 1 Small molecule)

Models (1)

Vilya

Released July 10, 2026

———

All-atom foundation model for macrocyclic peptide structure prediction, permeability estimation, and de novo design across non-canonical chemistries.

ProteinSmall molecule